… In summary, the development of biologic therapies has greatly advanced the field of rheumatoid
arthritis therapeutics; trials of additional biologics, the burgeoning development of small …

Rheumatoid arthritis (RA) is characterised by severe joint and bone damage due to heightened
autoimmune response at the articular sites. Worldwide annual incidence and prevalence …

… Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying
antirheumatic drugs versus treatment according to the pyramid approach in the first year. …

… for efficient rheumatoid arthritis-targeted delivery. … in clinical use for the treatment of arthritic
conditions. Pegloticase (… used for the treatment of Crohn's disease and rheumatoid arthritis. …

Rheumatoid arthritis (RA) is considered a chronic systemic, multi-factorial, inflammatory, and
progressive autoimmune disease affecting many people worldwide. While patients show …

… We used recently published recommendations on the treatment of rheumatoid arthritis.
We also searched the Cochrane Database of Systematic Reviews (without time limits) and …

… rheumatoid arthritis (RA) until about 2 decades ago. Disease modifying anti-rheumatic drug
(DMARD) treatment … different treatment strategies in patients with early rheumatoid arthritis (…

… Rheumatoid arthritis (RA) is one of more than 100 types of arthritis. This chronic … of the
early diagnosis and the development of new treatment options. Non-steroidal anti-inflammatory …

… We reviewed evidence for current and emerging treatment strategies in rheumatoid arthritis.
We searched the Medline database and Cochrane Library for articles dated from January …

… Rheumatoid arthritis is the most common form of inflammatory arthritis. Because of … Treatment
of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing …